|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Depreciation and other amortization | |||||
| Gain on change in fair value of warrant liability | |||||
| Stock-based compensation | |||||
| Write down of inventory, net | |||||
| Deferred income taxes provision (benefit) | |||||
| Deferred IV TPOXX® revenue | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable, accrued expenses and other liabilities | |||||
| Income tax payable | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Capital expenditures | |||||
| Cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Payment of employee tax obligations for common stock tendered | |||||
| Repurchase of common stock | |||||
| Payment of dividend | |||||
| Cash used in financing activities | |||||
| Net (decrease)/increase in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental disclosure of cash flows information: | |||||
| Non-cash lease right-of-use asset and associated liability | |||||
| Conversion of warrant to common stock | |||||
| Issuance of common stock | |||||
| Issuance of common stock upon cashless exercise | |||||
| Cash income taxes paid, net | |||||
Loading...